New Study Backs SGLT2 Inhibitors for Kidney Health in High-Risk Diabetes Cases: Study
Israel: A real-world analysis has provided new insights into the kidney-protective effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with diabetes and an insulin-deficient phenotype. The findings, published in Diabetes, Obesity and Metabolism, suggest that SGLT2 inhibitors slowed kidney function decline by 21% (HR 0.79) in insulin-deficient diabetes patients over 4.5 years. Users also had […]